Real life experiences
What does it mean to participants to take part a clinical study?
18th of January 2022 by Michael Wilch
“I am very grateful for the opportunity to take part in an INNODIA study.”
Being diagnosed with T1D at the age of 41 took me by surprise and challenged my daily routine in numerous aspects. As a newly diagnosed T1D I still have some own insulin secretion. This remaining secretion really helps me to manage my diabetes, as it allows me to do (small) mistakes in insulin calculation, which is very likely when you’re new to the business and at the same time trying to stick to your usual diet, job and flexibility.
It would be great for newly diagnosed T1D patients if it would be possible to extend the period of remaining insulin secretion! As this is one of the objectives of Vera-T1D, I fully share the goals of the study.
After I finished my studies in engineering some years ago I had the opportunity to stay at the university and do research, a time which I remember very positively. It is a wonderful feeling to try something new and be successful, being able to improve peoples’ lives. When I was newly diagnosed and still at the hospital I already searched the internet for ongoing studies on T1D and opportunities to take part. It was absolutely clear to me that there must be something good in me developing this disease: I have to do my part in advancing science in this field, to help all the people which will develop T1D in future. The best researcher can’t do anything if there is no opportunity to gather information and try new approaches.
It was absolutely clear to me that there must be something good in me developing this disease
THANK YOU, MICHAEL, for sharing your story with INNODIA
IF YOU HAVE QUESTIONS OR KNOW SOMEONE WHO HAS RECENLTY BEEN DIAGNOSED WITH TYPE 1 DIABETES, PLEASE DON’S HESITATE TO CONTACT US; INFO@INNODIA.EU OR FIND OUT MORE ON CLINICAL TRIAL PAGE.